INmune Bio

INMB

Market cap $37.2M

1.40 USD

-0.07

4.76%

At close Updated Apr 28, 4:00 PM EDT

Pre-market

After hours

1.41

+0.01

0.71%

1 day

-4.76%

5 days

-0.71%

1 month

22.81%

3 months

-13.04%

6 months

-23.08%

Year to date

-9.09%

1 year

-82.28%

5 years

-88.26%

10 years

-82.48%

About: INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Employees: 21

Healthcare Biotechnology